Moroccan businesswoman Lamia Tazi’s Sothema targets CIALIS assets from Eli Lilly
Moroccan businesswoman Lamia Tazi’s Sothema aims to acquire CIALIS assets from Eli Lilly to expand specialized therapies in Africa.
Lamia Tazi
Moroccan businesswoman Lamia Tazi leads Sothema’s purchase of Soludia Maghreb
Lamia Tazi’s Sothema will buy 99.99% of the dialysis solutions provider to boost local production.
Moroccan businesswoman Lamia Tazi's stake in Sothema nears $90 million
This boost comes on the heels of a strong rally in Sothema’s share price on the Casablanca Bourse.
Lamia Tazi gains $14 million from Sothema stake in 18 days
This upswing has further cemented her position among Morocco’s wealthiest individuals.
Moroccan pharma executive Lamia Tazi gains $8.14 million from Sothema stake
Tazi holds an 8.19 percent stake in Sothema, equivalent to 589,658 shares.
Moroccan pharma tycoon Lamia Tazi faces $3.35 million loss as Sothema shares dip
Lamia Tazi’s stake in Sothema dips below $65 million as shares slide
Moroccan pharma tycoon Lamia Tazi gains $3 million from Sothema stake in 28 days
This underscores Lamia Tazi’s leadership and strategic vision in steering Sothema to new heights in the competitive pharmaceutical industry.
Moroccan pharma tycoon Lamia Tazi suffers $2-million loss from Sothema stake
The recent financial setback experienced by Tazi underscores the broader challenges facing Sothema and highlights the unpredictable nature of the stock market.
Moroccan tycoon Lamia Tazi gains $2 million from Sothema stake in 8 days
The notable increase in the market value of Tazi’s stake in Sothema solidifies her position among the richest investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi’s Sothema stake slumps below $60 million
Despite the recent decline in her fortune, the Moroccan executive remains among the affluent investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi stake in Sothema rebounds above $60 million
Tazi’s recent financial gains are tied to the surge in Sothema’s stock on the Casablanca bourse.
Moroccan pharma tycoon Lamia Tazi suffers $3-million loss from Sothema stake
Tazi, the CEO and chairperson of Sothema holds a substantial 8.4-percent stake in the leading healthcare company.
Moroccan tycoon Lamia Tazi gains $6 million from Sothema stake in 15 days
The recent increase in the market value of her stake in Sothema solidifies her position among the richest investors on the Casablanca bourse.
Moroccan tycoon Lamia Tazi gains $3 million from Sothema stake in 32 days
Tazi, the chairperson of Sothema and one of the wealthiest investors on the Casablanca bourse owns an 8.4-percent stake in the leading healthcare group.
Moroccan tycoon Lamia Tazi loses $2.8 million from Sothema stake
Lamia Tazi, the CEO and chairperson of Sothema and one of the most affluent investors on the Casablanca Stock Exchange, holds an 8.4-percent stake in the healthcare company